Donate
Search wpr.org

Understanding the new weight-loss drugs

Air Date:
Heard On The Morning Show
A person measuring another person's waist with a tape measurer
In this Jan. 20, 2010 file photo, a subject’s waist is measured during an obesity prevention study in Chicago. Obesity rates in the U.S. have been rising steadily for well over a decade and some of the world’s biggest drug developers are tapping into the growing treatment market. Novo Nordisk reported another surge in profits and revenue during its most recent quarter with a big assist from Wegovy, an injectable treatment for weight loss approved by the Food and Drug Administration in 2021. M. Spencer Green/ AP Photo

A new class of drugs like Ozempic and Wegovy have been called “game changers” for their potential to help Americans who are overweight, diabetic or suffering from addictions. An endocrinologist from UW Health explains what you should know about these drugs and other weight-loss treatments.

Episode Credits

  • Kate Archer Kent Host
  • Joe Tarr Producer
  • Lee Rayburn Technical Director
  • Dr. Dawn B. Davis Guest

Wisconsin Public Radio, © Copyright 2024, Board of Regents of the University of Wisconsin System and Wisconsin Educational Communications Board.

Related Stories